placeholder image
J. F. Schwerkoske All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG). 
    Journal of Neuro-Oncology. 2019
  • Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572. 
    Cancer. 2018
    • Contact
    full name
  • J. F. Schwerkoske
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration